Matinas BioPharma Holdings, Inc.
MTNB
$0.65
$0.0599.98%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 6.12% | -33.58% | |||
| Gross Profit | -6.12% | 33.58% | |||
| SG&A Expenses | -22.41% | -13.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.83% | -24.97% | |||
| Operating Income | 7.83% | 24.97% | |||
| Income Before Tax | -99.13% | 25.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -97.26% | 25.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -97.26% | 25.25% | |||
| EBIT | 7.83% | 24.97% | |||
| EBITDA | 7.97% | 25.37% | |||
| EPS Basic | -95.29% | 26.00% | |||
| Normalized Basic EPS | 5.47% | 25.99% | |||
| EPS Diluted | -95.29% | 26.00% | |||
| Normalized Diluted EPS | 5.47% | 25.99% | |||
| Average Basic Shares Outstanding | 1.01% | 1.02% | |||
| Average Diluted Shares Outstanding | 1.01% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||